Vimarsana
Biggest News Aggregation in the World

Viropharma Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Viropharma Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Viropharma Inc Today - Breaking & Trending Today

Ligand Pharmaceuticals Expands Senior Leadership Team with Two Key Hires - Vimarsana News

Ligand Pharmaceuticals Expands Senior Leadership Team with Two Key Hires

Expansion Deepens Ligand’s Commercial, Clinical and Investment Expertise ...

Arbutus Announces CEO, William Collier, to Retire December 31, 2023 - Arbutus Biopharma (NASDAQ:ABUS) - Vimarsana News

Arbutus Announces CEO, William Collier, to Retire December 31, 2023 - Arbutus Biopharma (NASDAQ:ABUS)

Michael J. McElhaugh, Arbutus Co-founder and COO, to Serve as Interim CEO WARMINSTER, Pa., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (NASDAQ:ABUS) ("Arbutus" or the "Company"), a clinical-stage

The Nucleus: Life Sciences Enforcement and Regulatory Updates | Skadden, Arps, Slate, Meagher & Flom LLP - Vimarsana News

The Nucleus: Life Sciences Enforcement and Regulatory Updates | Skadden, Arps, Slate, Meagher & Flom LLP

In this issue of our newsletter on developments impacting the life sciences industry, we examine topics including how the increased DOJ and FDA focus on cybersecurity issues could lead...

Texas Attorney General's Office recovers $42 million from Medicaid fraud - Vimarsana News

Texas Attorney General's Office recovers $42 million from Medicaid fraud

(The Center Square) – The Office of the Attorney General’s Civil Medicaid Fraud Division settled an enforcement action brought under the Texas Medicaid Fraud Prevention Act against several pharmaceutical drug

Sintetica establishes US entity - Vimarsana News

Sintetica establishes US entity

MENDRISIO, Switzerland, Oct. 14, 2022 /PRNewswire/ -- Sintetica, a Swiss pharmaceutical company headquartered in Mendrisio specializing in injectables in the field of pain therapy, has taken